{"AllianceGenome": "2336", "HGNC": "2336", "MIM": "120650", "_id": "1380", "_version": 1, "accession": {"genomic": ["AF223941.1", "AF298224.1", "AH003614.2", "AL391597.15", "AL691452.10", "CH471100.2", "CP068277.2", "EF064746.1", "NC_000001.11", "NC_060925.1", "NG_013006.1", "S56785.1", "X98257.1"], "protein": ["AAA35784.1", "AAA35786.1", "AAB04638.1", "AAB27186.1", "AAG37227.1", "AAH90937.1", "AAI36395.1", "ABK41929.1", "BAD97347.1", "BAG63007.1", "CAA48779.1", "CAA66910.1", "CAA68674.1", "EAW93481.1", "EAW93482.1", "EAW93483.1", "NP_001006659.1", "NP_001868.2", "P20023.2"], "rna": ["AI765035.1", "AK223627.1", "AK301496.1", "AU133057.1", "AW303499.1", "BC032548.1", "BC090937.1", "BC136394.1", "BQ004295.1", "J03565.1", "M26004.1", "M26317.1", "NM_001006658.3", "NM_001877.5", "S62696.1", "X68990.1", "Y00649.1"], "translation": [{"protein": "AAA35784.1", "rna": "J03565.1"}, {"protein": "AAA35786.1", "rna": "M26004.1"}, {"protein": "CAA48779.1", "rna": "X68990.1"}, {"protein": "AAI36395.1", "rna": "BC136394.1"}, {"protein": "CAA68674.1", "rna": "Y00649.1"}, {"protein": "AAH90937.1", "rna": "BC090937.1"}, {"protein": "NP_001868.2", "rna": "NM_001877.5"}, {"protein": "BAG63007.1", "rna": "AK301496.1"}, {"protein": "AAB27186.1", "rna": "S62696.1"}, {"protein": "BAD97347.1", "rna": "AK223627.1"}, {"protein": "NP_001006659.1", "rna": "NM_001006658.3"}]}, "alias": ["C3DR", "CD21", "CR", "CVID7", "SLEB9"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2021-08-03T13:00:56.511Z", "disease_label": "immunodeficiency, common variable, 7", "gcep": "Antibody Deficiencies Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0013862", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9153b41e-f2ef-453d-883b-187565cf4593-2021-08-03T130056.511Z", "sop": "SOP8"}}, "ensembl": {"gene": "ENSG00000117322", "protein": ["ENSP00000356024", "ENSP00000356025", "ENSP00000356026", "ENSP00000491608", "ENSP00000514480", "ENSP00000514481", "ENSP00000514493"], "transcript": ["ENST00000367057", "ENST00000367058", "ENST00000367059", "ENST00000475194", "ENST00000479186", "ENST00000485707", "ENST00000640301", "ENST00000699620", "ENST00000699621", "ENST00000699640"], "translation": [{"protein": "ENSP00000514493", "rna": "ENST00000699640"}, {"protein": "ENSP00000356025", "rna": "ENST00000367058"}, {"protein": "ENSP00000356026", "rna": "ENST00000367059"}, {"protein": "ENSP00000356024", "rna": "ENST00000367057"}, {"protein": "ENSP00000514480", "rna": "ENST00000699620"}, {"protein": "ENSP00000514481", "rna": "ENST00000699621"}, {"protein": "ENSP00000491608", "rna": "ENST00000640301"}], "type_of_gene": "protein_coding"}, "entrezgene": "1380", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 41.4645771822, "exp_mis": 349.929738071, "exp_syn": 136.910596596, "lof_z": 2.68663789520672, "mis_z": -0.00183815158000151, "mu_lof": 3.0218089916e-06, "mu_mis": 3.08132398142e-05, "mu_syn": 1.17844566749e-05, "n_lof": 24.0, "n_mis": 350.0, "n_syn": 141.0, "p_li": 2.16539872051034e-11, "p_null": 0.00954543671207967, "p_rec": 0.990454563266266, "syn_z": -0.216665871611927}, "bp": 3279, "cds_end": 207658899, "cds_start": 207627763, "n_exons": 19, "nonpsych": {"exp_lof": 37.1487082238, "exp_mis": 316.339453864, "exp_syn": 123.536574552, "lof_z": 2.44093217615883, "mis_z": 0.0379863599372621, "mu_lof": 3.0218089916e-06, "mu_mis": 3.08132398142e-05, "mu_syn": 1.17844566749e-05, "n_lof": 22.0, "n_mis": 315.0, "n_syn": 123.0, "p_li": 1.32116976391002e-10, "p_null": 0.0206143353377293, "p_rec": 0.979385664530154, "syn_z": 0.0303959956972322}, "nontcga": {"exp_lof": 38.1103009353, "exp_mis": 321.898270609, "exp_syn": 125.920651246, "lof_z": 2.57432693980624, "mis_z": 0.0249435180686229, "mu_lof": 3.0218089916e-06, "mu_mis": 3.08132398142e-05, "mu_syn": 1.17844566749e-05, "n_lof": 22.0, "n_mis": 321.0, "n_syn": 126.0, "p_li": 1.73731258285876e-10, "p_null": 0.011641854971282, "p_rec": 0.988358144854987, "syn_z": -0.0044745247574919}, "transcript": "ENST00000367057.3"}, "exons": [{"cdsend": 207485554, "cdsstart": 207454418, "chr": "1", "position": [[207454327, 207454476], [207466525, 207466912], [207468526, 207468715], [207468799, 207468899], [207469149, 207469232], [207469694, 207470102], [207470739, 207470916], [207470996, 207471087], [207471422, 207471499], [207472771, 207473179], [207473544, 207473721], [207473800, 207473885], [207474240, 207474323], [207474823, 207475216], [207476233, 207476419], [207477884, 207478070], [207479256, 207479280], [207479977, 207480053], [207485463, 207485572], [207489141, 207489892]], "strand": 1, "transcript": "NM_001006658", "txend": 207489892, "txstart": 207454327}, {"cdsend": 207485554, "cdsstart": 207454418, "chr": "1", "position": [[207454327, 207454476], [207466525, 207466912], [207468526, 207468715], [207468799, 207468899], [207469149, 207469232], [207469694, 207470102], [207470739, 207470916], [207470996, 207471087], [207471422, 207471499], [207472771, 207473179], [207473800, 207473885], [207474240, 207474323], [207474823, 207475216], [207476233, 207476419], [207477884, 207478070], [207479256, 207479280], [207479977, 207480053], [207485463, 207485572], [207489141, 207489892]], "strand": 1, "transcript": "NM_001877", "txend": 207489892, "txstart": 207454327}], "exons_hg19": [{"cdsend": 207658899, "cdsstart": 207627763, "chr": "1", "position": [[207627672, 207627821], [207639870, 207640257], [207641871, 207642060], [207642144, 207642244], [207642494, 207642577], [207643039, 207643447], [207644084, 207644261], [207644341, 207644432], [207644767, 207644844], [207646116, 207646524], [207646889, 207647066], [207647145, 207647230], [207647585, 207647668], [207648168, 207648561], [207649578, 207649764], [207651229, 207651415], [207652601, 207652625], [207653322, 207653398], [207658808, 207658917], [207662486, 207663237]], "strand": 1, "transcript": "NM_001006658", "txend": 207663237, "txstart": 207627672}, {"cdsend": 207658899, "cdsstart": 207627763, "chr": "1", "position": [[207627672, 207627821], [207639870, 207640257], [207641871, 207642060], [207642144, 207642244], [207642494, 207642577], [207643039, 207643447], [207644084, 207644261], [207644341, 207644432], [207644767, 207644844], [207646116, 207646524], [207647145, 207647230], [207647585, 207647668], [207648168, 207648561], [207649578, 207649764], [207651229, 207651415], [207652601, 207652625], [207653322, 207653398], [207658808, 207658917], [207662486, 207663237]], "strand": 1, "transcript": "NM_001877", "txend": 207663237, "txstart": 207627672}], "generif": [{"pubmed": 8996252, "text": "Follicular dendritic cells express alternative splice form of CR2/CD21, containing one extra exon"}, {"pubmed": 11466369, "text": "The binding of CR2 to EBV surface glycoprotein gp350/220 follows a simple 1:1 interaction, whereas that of the receptor's natural ligands C3d and iC3b is more complex and involves more than one intramolecular component."}, {"pubmed": 11739509, "text": "promoter activity is critically dependent on a cell type-specific repressor"}, {"pubmed": 11813981, "text": "Redox control of EBV infection: prevention by thiol-dependent modulation of functional CD21/EBV receptor expression."}, {"pubmed": 11981823, "text": "relative contributions of CR1 and CR2 to the deposition of C3 fragments and MAC on B lymphocytes under circumstances where all complement pathways are operational"}, {"pubmed": 12122212, "text": "crystal structure of human CD21; implications for epstein-barr virus and c3d binding"}, {"pubmed": 12149502, "text": "The percentage of T cells expressing CD21 from all gestations was significantly higher than the adult and the percentage positive decreased with increasing gestational age."}, {"pubmed": 12444129, "text": "NF-kappaB signaling pathway enhances the expression of the CR2 gene, as a result of NF-kappaB proteins binding to two CR2 promoter elements."}, {"pubmed": 12546713, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12713795, "text": "CR2 is shed mainly as a soluble CR2 complex, in which the CR2 units link covalently and react with nucleophilic agents"}, {"pubmed": 12813023, "text": "Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation."}, {"pubmed": 14607925, "text": "Coligation of CD21 with the B cell antigen receptor lowers the antigen concentration threshold for eliciting protection from Fas apoptosis by 2-3 orders of magnitude."}, {"pubmed": 14635039, "text": "Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes."}, {"pubmed": 15187133, "text": "electrostatic calculations provide global and site-specific explanations of the physical causes that underlie the ionic strength dependence of C3d-CR2 association"}, {"pubmed": 15603708, "text": "The activation of MAPKs is independently mediated by CR2 and that anti-CR2 McAb, PD98059, and Wortmanin block the activation of MAPKs, respectively."}, {"pubmed": 15713467, "text": "characterized the interaction between the first two short consensus repeats (SCR1-2) of complement receptor type 2 (CR2, CD21) and C3d"}, {"pubmed": 15713468, "text": "the open V-shaped structures formed by CR2 SCR 1-2, both when free and when bound to C3d, are optimal for the formation of a tight two-domain interaction with its ligand C3d"}, {"pubmed": 15795251, "text": "CD21 and CD23a are common targets for B lymphotropic gammaherpesviruses."}, {"pubmed": 15905540, "text": "Unresponsiveness to T-dependent antigen (sheep red blood cells) displayed by transgenic CR2-positive B cells is linked to increase in the stimulus level required to propel the B cell into a fully activated state, a normal humoral immune response."}, {"pubmed": 16289966, "text": "CD21 activation triggered Cbl tyrosine phosphorylation, which interacts with SH2 domains of p85 subunit, SH2 domains of Crk-L and with tyrosine phosphorylated Syk kinase.  CD21 activation triggers dissociation of Cbl-Vav complex."}, {"pubmed": 16375923, "text": "Results describe the domain structure of complement receptor 2 engineered with the Fc fragment of a mouse IgG1 in solution."}, {"pubmed": 16740600, "text": "shedding of CD21 and CD62L is mediated via the P2X7R."}, {"pubmed": 16785534, "text": "CR2 binds interferon-alpha in the same affinity range as the other three well-characterized ligands studied in parallel: CD23, C3d, and Epstein-Barr virus glycoprotein 350."}, {"pubmed": 16803874, "text": "CD21 shedding is a redox-regulated process inducible by oxidation presumably through activation of a tyrosine kinase-mediated signal pathway involving protein kinase C (PKC)."}, {"pubmed": 16920989, "text": "factor I in concert with CR1 on E and factor H in serum due to their cofactor activity are likely to be important contributors"}, {"pubmed": 16987062, "text": "CD4, complement receptors, and CXCR4 chemokine receptors are required for complement mediated antibody dependent enhanced entry of HIV into MT2 cells."}, {"pubmed": 17118449, "text": "Four novel partners that are involved in intracellular trafficking, sorting or cytoskeleton remodeling were identified and the hCD21 transmembrane and tail subdomains they interact with, were mapped."}, {"pubmed": 17301948, "text": "Premature transgenic CR2 expression and the consequences thereof during B cell development intrinsically alters the way mature B cells develop and subsequently respond to antigen through the B cell receptor signaling complex."}, {"pubmed": 17360460, "text": "CR2 participates in the pathogenesis of systemic lupus erythematosus"}, {"pubmed": 17360460, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17881405, "text": "no strong association between variation in the CR2 receptor gene and risk in multiple sclerosis"}, {"pubmed": 18174230, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18500464, "text": "The serum sCD21 levels during pregnancy are significantly lower as compared to that of the healthy controls;Restoration of sCD21 levels to normal values takes between 6 weeks and 1 year"}, {"pubmed": 18568448, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 18713965, "text": "REVIEW: comparison of CR2 protein structure, gene structure and function for mouse nad human"}, {"pubmed": 18804116, "text": "This is the first solution structural study of a large multidomain short complement regulator protein CR2 bound to its physiological ligand C3d."}, {"pubmed": 18842294, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19017934, "text": "members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2"}, {"pubmed": 19164292, "text": "C3dp1 interacts at the same CR2 site as C3d"}, {"pubmed": 19187965, "text": "mice expressing hCR2 on their B cells during bone marrow development display a higher degree of apoptosis which may lead to a deletion of autoreactive B cells and be protective against the development of autoimmune disease."}, {"pubmed": 19193442, "text": "CD21-dependent viral entry plays a crucial role in type 2 alveolar epithelial cells, indicative of an IL-4 response EBV infection in idiopathic pulmonary fibrosis."}, {"pubmed": 19344414, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19359041, "text": "Analysis of aged hCR2(high) mice (1 year plus) showed that both B cell numbers, B cell sub-population distribution including expansion of a newly described B regulatory cell subset, and immune responses were comparable with age-matched hCR2 negative mice."}, {"pubmed": 19360456, "text": "CD21 is tightly related to LFA-1 expression in B-cell lymphoma (BCL) and the absence of CD21/LFA-1 expression is associated with pleural/peritoneal fluid involvement by BCL"}, {"pubmed": 19387458, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19387458, "text": "Study confirms previous association of rs3813946, rs1048971, and rs17615 with systemic lupus erythematosus (SLE) susceptibility, and show association of 2 additional CR2 SNPs with SLE, identify a protective CR2 haplotype containing these SNPs."}, {"pubmed": 19487031, "text": "Both CBF1 and C/EBP-beta bind the CR2 promoter in B cells raising the possibility that these factors facilitate or respond to alterations in chromatin structure to control the timing and/or level of CR2 transcription."}, {"pubmed": 19524299, "text": "Data show that B cell activation led to increased CD21-CTF levels, suggesting a functional role for the CD21-CTFs in B cell activation and maintenance of B cell homeostasis."}, {"pubmed": 19666505, "text": "CD21(low) B cells represent a human innate-like B cell population."}, {"pubmed": 19740327, "text": "CR2-induced complement activation results in membrane depolarization, as indicated by annexin V binding, with kinetics similar to those of C3-fragment deposition and different from those of membrane attack complex formation."}, {"pubmed": 20083651, "text": "Staphylococcus aureus binder of Ig (Sbi) and complement receptor 2 (CR2) share overlapping binding sites on complement 3d (C3d), thus allowing the bacterial evasion molecule to block CR2 binding, thereby inhibiting the host's adaptive immune response."}, {"pubmed": 20091675, "text": "analysis of the physicochemical properties underlying C3d-CR2 association"}, {"pubmed": 20237496, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20558730, "text": "Biophysical investigations of complement receptor 2 (CD21 and CR2)-ligand interactions reveal amino acid contacts unique to each receptor-ligand pair"}, {"pubmed": 20951140, "text": "Molecular modeling approaches used to investigate disparities between the biochemical data and the X-ray structure of the CR2-C3d cocrystal result in highest-scoring solutions in which CR2 SCR1-2 is docked within the concave surface of C3d."}, {"pubmed": 21052675, "text": "Prevalence of pulmonary fibrosis in patients with diffuse cutaneous systemic sclerosis inversely correlates with soluble cluster of differentiation 21 (sCD21) levels."}, {"pubmed": 21106852, "text": "Binding between Epstein Barr virus-transformed B cell line-derived exosomes and viral structural protein gp350 is dependent on CD21 expressed on the B cells."}, {"pubmed": 21269698, "text": "The impact of hCR2 expression on mouse B cell development and the baseline immunological status of the mice, was evaluated."}, {"pubmed": 21328056, "text": "All subtypes of juvenile arthritis have reduced circulating levels of sCD21 and sCD23."}, {"pubmed": 21527715, "text": "study reports a cocrystal structure of a CR2(SCR1-2):C3d complex at 3.2 angstrom resolution in which the interaction interfaces differ markedly from the previously published structure and are consistent with the biochemical data"}, {"pubmed": 21889131, "text": "CD23 oligomers appear more important in enhancing IgE synthesis and monomers lacking the tail residues fail to bind CD21 yet bind membrane IgE and down-regulate IgE synthesis."}, {"pubmed": 22084433, "text": "Patients with hepatitis C virus infection who display high frequencies of unresponsive CD21(-/low) marginal zone B cells are more susceptible to developing autoimmunity and/or lymphoproliferation."}, {"pubmed": 22137275, "text": "CD21 expression is altered in multiple sclerosis (MS) patients as in other autoimmune diseases, although no evidence is found for a specific role of the CD21 gene in MS."}, {"pubmed": 22673213, "text": "the 5' UTR is a novel regulatory element for the CR2 gene in which variation may alter gene function and modify the development of Systemic lupus erythematosus"}, {"pubmed": 22678901, "text": "Marginal zone B cells activated by hepatitis C virus undergo functional exhaustion associated with BCR signaling defects and overexpression of a key antiproliferative gene, and may subsequently become terminally spent CD21(low) B cells."}, {"pubmed": 22885687, "text": "These results suggest that CR2 plays a role in the recognition of foreign DNA during host-immune responses"}, {"pubmed": 22899340, "text": "plasma sCD21 levels are higher, while B-cell surface CD21 expression levels are lower in B-cell chronic lymphocytic leukemia (B-CLL) patients, but not in multiple myeloma (MM) patients."}, {"pubmed": 23002439, "text": "Transgenic mice inoculated with elk brain homogenate expressing high levels of prion (PrPC) protein die of chronic wasting disease."}, {"pubmed": 23279883, "text": "Patients with primary Sjogren's Syndrome who display high frequencies of autoreactive and unresponsive CD21-/low B cells are susceptible to developing lymphoproliferation."}, {"pubmed": 23384704, "text": "To eradicate this virus, targeting CD21 on these EBV-infected B cells is hypothesized here."}, {"pubmed": 23612877, "text": "Our findings implicate CR2 as a susceptibility gene for nasopharyngeal carcinoma and suggest that enhanced CR2 expression may be involved in the oncogenesis and development of nasopharyngeal carcinoma."}, {"pubmed": 24600013, "text": "Authors show that expression of the Epstein-Barr virus B-cell attachment receptor, CD21, in B cells that lack this receptor results in significant changes in gene expression, both before and rapidly following EBV-CD21 interaction."}, {"pubmed": 24675670, "text": "Higher C3d/C3 ratios were found for current smoker, higher age, age-related macular degeneration phenotype, and the two SNPs in the C3 gene, rs6795735 and rs2230199."}, {"pubmed": 25180293, "text": "These data suggest that rs1876453 in CR2 has long-range effects on gene regulation that decrease susceptibility to systemic lupus erythematosus."}, {"pubmed": 25385064, "text": "The paradoxical enhancement of immune responses by C3d in the absence of CD21 is due to internalization and processing of C3d into peptides that activate autoreactive CD4(+) T-helper cells."}, {"pubmed": 25569262, "text": "found that the protective CR2 genotype is correlated with lower levels CR2 mRNA as well as differences in the ratio of the long and short CR2 isoforms"}, {"pubmed": 25640655, "text": "In mature B cells, CD21 transcription proceeds from a focused transcriptional start site regulated by a non-consensus TATA box, an initiator element and a downstream promoter element."}, {"pubmed": 25817480, "text": "repression of the CR2/CD21 promoter can occur through one of the E-box motifs via recruitment of RP58."}, {"pubmed": 26189291, "text": "THE COMBINATION OF EXPRESSION OF MARKERS CR1 AND CR2 (CD35/CD21) IN DIAGNOSTIC OF B-CELL LYMPHOPROLIFERATIVE DISEASES"}, {"pubmed": 26452134, "text": "Reduced expression of CD21 on CLL B-cells appears functionally relevant and was associated with poor clinical outcomes."}, {"pubmed": 26748973, "text": "In this study, we have shown that the CR2 +24T>C polymorphism is not a risk marker for nasopharyngeal carcinoma development in the North region of Portugal."}, {"pubmed": 27085202, "text": "Cerebrospinal fluid (CSF) soluble complement receptor 2 (sCR2) levels correlated significantly both with CSF complements C3 and C1q as well as to a disease severity measure."}, {"pubmed": 27154286, "text": "This study uncovers the origin of the effect of ionic strength on C3d-CR2 interaction and deepens the understanding of the molecular mechanism of their interaction, which is valuable for the design of vaccines and small molecule inhibitors."}, {"pubmed": 27412887, "text": "Binding of PF4/heparin complexes to B cells is mediated through the interaction between complement and complement receptor 2."}, {"pubmed": 27446959, "text": "CR2 contributes to human Osteonecrosis of the femoral head susceptibility in Korean systemic lupus erythematosus patients."}, {"pubmed": 27778395, "text": "This study shown the C3d+ microglial clusters were found in chronic but not acute multiple sclerosis."}, {"pubmed": 28499783, "text": "this study shows CD21 deficiency in 2 siblings with recurrent respiratory infections and hypogammaglobulinemia"}, {"pubmed": 28507081, "text": "high pERK expression and accelerated apoptosis revert within 4 weeks after beginning therapy, whereas clonal B cells unresponsive to TLR9 stimulation persist for at least 24 weeks, although they may partially rescue normal CD21 expression."}, {"pubmed": 29515028, "text": "Study reported that low CD19/CD21 expression is a general early feature of B cells in systemic lupus erythematosus (SLE) and is associated with an impairment of TLR9 response in these cells. Plasmacytoid dendritic cells from SLE patients that express TLR9, but not CD19, display normal TLR9 function. Thus, decreased CD19/CD21 expression combined with defective TLR9 function may fail to prevent autoreactive B cell death."}, {"pubmed": 30107486, "text": "FCRL5 has dual signaling capacity, while CD21 co-engagement serves as molecular switch, converting FCRL5 from a negative to a positive co-receptor; in tissues, B cells that co-express FCRL5 and CD21 could robustly respond to IgG immune complexes loaded with C3 fragments"}, {"pubmed": 30114200, "text": "Our data indicate that a distinct inflammatory process accompanies IL17A and CD21L co-expression. Clearly B-cells are involved and their prominence indicates that therapies targeting B-cells, such as rituximab, are likely to be more efficacious towards IL17A+/CD21L+ synovia."}, {"pubmed": 31634193, "text": "Association of complement C3d receptor 2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 vaccine."}, {"pubmed": 32238579, "text": "CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells."}, {"pubmed": 32552036, "text": "Association Between Genetic Polymorphisms of CR2 Gene and the Risk of Steroid-Induced Osteonecrosis of the Femoral Head in the Chinese Han Male Population."}, {"pubmed": 32907998, "text": "Naive- and Memory-like CD21(low) B Cell Subsets Share Core Phenotypic and Signaling Characteristics in Systemic Autoimmune Disorders."}, {"pubmed": 33129017, "text": "Notch signaling induces a transcriptionally permissive state at the Complement C3d Receptor 2 (CR2) promoter in a pre-B cell model."}, {"pubmed": 33143694, "text": "High proportion of anergic B cells in the bone marrow defined phenotypically by CD21(-/low)/CD38- expression predicts poor survival in diffuse large B cell lymphoma."}, {"pubmed": 33868238, "text": "Revisiting the Coreceptor Function of Complement Receptor Type 2 (CR2, CD21); Coengagement With the B-Cell Receptor Inhibits the Activation, Proliferation, and Antibody Production of Human B Cells."}, {"pubmed": 34623902, "text": "The expansion of human T-bet(high)CD21(low) B cells is T cell dependent."}, {"pubmed": 36971659, "text": "Identification and Characterization of chCR2, a Protein That Binds Chicken Complement Component 3d."}, {"pubmed": 37833411, "text": "Complement receptor type 1 and 2 (CR1 and CR2) gene polymorphisms and plasma protein levels are associated with the Dengue disease severity."}, {"pubmed": 38287771, "text": "Oral lupus erythematosus: Immunohistochemical evaluation of CD1a, CD21, CD123, and langerin expression in dendritic cells."}], "genomic_pos": {"chr": "1", "end": 207489895, "ensemblgene": "ENSG00000117322", "start": 207453024, "strand": 1}, "genomic_pos_hg19": {"chr": "1", "end": 207663240, "start": 207627575, "strand": 1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0002430", "qualifier": "involved_in", "term": "complement receptor mediated signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0002456", "qualifier": "involved_in", "term": "T cell mediated immunity"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0006955", "pubmed": 2827171, "qualifier": "involved_in", "term": "immune response"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006957", "pubmed": 11981823, "qualifier": "involved_in", "term": "complement activation, alternative pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006958", "qualifier": "involved_in", "term": "complement activation, classical pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0030183", "pubmed": 2995485, "qualifier": "involved_in", "term": "B cell differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0042100", "pubmed": 2995485, "qualifier": "involved_in", "term": "B cell proliferation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0045959", "qualifier": "involved_in", "term": "negative regulation of complement activation, classical pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0046718", "qualifier": "involved_in", "term": "symbiont entry into host cell"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005615", "qualifier": "is_active_in", "term": "extracellular space"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0016020", "pubmed": 2827171, "qualifier": "located_in", "term": "membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0043235", "pubmed": 23382219, "qualifier": "part_of", "term": "receptor complex"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": 20458337, "qualifier": "located_in", "term": "extracellular exosome"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0001618", "qualifier": "enables", "term": "virus receptor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0001848", "pubmed": 11034390, "qualifier": "enables", "term": "complement binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003677", "pubmed": 22885687, "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "NAS", "id": "GO:0004875", "pubmed": 2827171, "qualifier": "enables", "term": "complement receptor activity"}, {"category": "MF", "evidence": "NAS", "id": "GO:0004888", "pubmed": 2827171, "qualifier": "enables", "term": "transmembrane signaling receptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [7753047, 11387479, 16172256, 21527715], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0034987", "pubmed": 16172256, "qualifier": "enables", "term": "immunoglobulin receptor binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0042803", "pubmed": 11728339, "qualifier": "enables", "term": "protein homodimerization activity"}]}, "homologene": {"genes": [[9544, 714202], [9598, 457690], [9606, 1380], [9615, 490269], [9913, 407126], [10090, 12902], [10116, 289395]], "id": 55611}, "interpro": [{"desc": "Sushi/SCR/CCP domain", "id": "IPR000436", "short_desc": "Sushi_SCR_CCP_dom"}, {"desc": "Sushi/SCR/CCP superfamily", "id": "IPR035976", "short_desc": "Sushi/SCR/CCP_sf"}], "ipi": ["IPI00216985", "IPI00216986", "IPI00216987", "IPI00292859", "IPI00844261", "IPI00953263"], "map_location": "1q32.2", "name": "complement C3d receptor 2", "other_names": ["EBV receptor", "complement component (3d/Epstein Barr virus) receptor 2", "complement component 3d receptor 2", "complement receptor type 2"], "pantherdb": {"HGNC": "2336", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "88489", "ortholog_type": "LDO", "panther_family": "PTHR19325", "taxid": 10090, "uniprot_kb": "P19070"}, {"RGD": "1310065", "ortholog_type": "LDO", "panther_family": "PTHR19325", "taxid": 10116, "uniprot_kb": "A0A0G2K684"}, {"Ensembl": "ENSGALG00000023950", "ortholog_type": "O", "panther_family": "PTHR19325", "taxid": 9031, "uniprot_kb": "F1P386"}, {"Ensembl": "ENSGALG00000030007", "ortholog_type": "O", "panther_family": "PTHR19325", "taxid": 9031, "uniprot_kb": "A0A3Q2UGQ0"}, {"ZFIN": "ZDB-GENE-041014-221", "ortholog_type": "O", "panther_family": "PTHR19325", "taxid": 7955, "uniprot_kb": "F1QIT5"}, {"Ensembl": "ENSDARG00000013526", "ortholog_type": "O", "panther_family": "PTHR19325", "taxid": 7955, "uniprot_kb": "A0A1D5NSM8"}, {"FlyBase": "FBgn0001083", "ortholog_type": "O", "panther_family": "PTHR19325", "taxid": 7227, "uniprot_kb": "Q9VYR4"}, {"FlyBase": "FBgn0032797", "ortholog_type": "O", "panther_family": "PTHR19325", "taxid": 7227, "uniprot_kb": "B7YZX0"}, {"FlyBase": "FBgn0030617", "ortholog_type": "O", "panther_family": "PTHR19325", "taxid": 7227, "uniprot_kb": "A8JUX3"}, {"FlyBase": "FBgn0010114", "ortholog_type": "O", "panther_family": "PTHR19325", "taxid": 7227, "uniprot_kb": "Q09101"}], "uniprot_kb": "P20023"}, "pathway": {"kegg": [{"id": "hsa04610", "name": "Complement and coagulation cascades - Homo sapiens (human)"}, {"id": "hsa04640", "name": "Hematopoietic cell lineage - Homo sapiens (human)"}, {"id": "hsa04662", "name": "B cell receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa05169", "name": "Epstein-Barr virus infection - Homo sapiens (human)"}], "netpath": {"id": "Pathway_BCR", "name": "BCR"}, "reactome": [{"id": "R-HSA-166658", "name": "Complement cascade"}, {"id": "R-HSA-168249", "name": "Innate Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-977606", "name": "Regulation of Complement cascade"}], "wikipathways": [{"id": "WP23", "name": "B Cell Receptor Signaling Pathway"}, {"id": "WP2806", "name": "Complement system"}, {"id": "WP3941", "name": "Oxidative Damage"}, {"id": "WP4950", "name": "16p11.2 distal deletion syndrome"}, {"id": "WP558", "name": "Complement and Coagulation Cascades"}]}, "pdb": ["1GHQ", "1LY2", "1W2R", "1W2S", "2ATY", "2GSX", "3OED"], "pfam": "PF00084", "pharmgkb": "PA26857", "pharos": {"target_id": 13886, "tdl": "Tbio"}, "pir": "JL0028", "prosite": "PS50923", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF214510", "relationship": "is"}, {"id": "GNF247863", "relationship": "is"}, {"id": "GNF247864", "relationship": "is"}, {"id": "GNF247865", "relationship": "is"}, {"id": "GNF247866", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF047878", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF081256", "relationship": "is"}, {"id": "GNF081257", "relationship": "is"}, {"id": "GNF081258", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051024", "relationship": "is"}, {"id": "GNF055791", "relationship": "is"}, {"id": "GNF060475", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF065971", "relationship": "is"}, {"id": "GNF065972", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF130617", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF097508", "relationship": "is"}, {"id": "GNF137163", "relationship": "is"}, {"id": "GNF152346", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NG_013006.1"], "protein": ["NP_001006659.1", "NP_001868.2"], "rna": ["NM_001006658.3", "NM_001877.5"], "translation": [{"protein": "NP_001006659.1", "rna": "NM_001006658.3"}, {"protein": "NP_001868.2", "rna": "NM_001877.5"}]}, "reporter": {"HG-U133_Plus_2": ["205544_s_at", "244097_at"], "HG-U95Av2": "36874_at", "HTA-2_0": ["TC01001737.hg.1", "TC01004988.hg.1"], "HuEx-1_0": "2377283", "HuGene-1_1": "7909350", "HuGene-2_1": "16676795"}, "summary": "This gene encodes a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes. Genetic variations in this gene are associated with susceptibility to systemic lupus erythematosus type 9 (SLEB9). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009].", "symbol": "CR2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1413696"}, "unigene": "Hs.445757", "uniprot": {"Swiss-Prot": "P20023", "TrEMBL": ["A0A8V8TQA3", "A0A8V8TPX6", "A0A1W2PPV2", "A0A8V8TNI2", "Q5SR47"]}, "wikipedia": {"url_stub": "Complement receptor 2"}}